Back to search

Article

Doxorubicin-Induced p53 Interferes with Mitophagy in Cardiac Fibroblasts

2019-06-17

Abstract excerpt

Doxorubicin is a mainstay in pediatric chemotherapy treatment because of its efficacy treating leukemia and lymphoma. Unfortunately, every childhood cancer survivor will develop a chronic health problem, one of the most serious being cardiac disease. How doxorubicin damages the heart in such a way that disease progression occurs over multiple decades is still not understood. The dose of doxorubicin selected does n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19f08e2b-e226-5a47-97b6-53e1712d8362
DOI
10.1101/674309
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Doxorubicin-Induced p53 Interferes with Mitophagy in Cardiac FibroblastsDOI 10.1101/674309
Select a neighboring publication to make it the new centre.